Alzheimer’s disease remains one of the most pressing challenges in modern medicine, ranking as a leading cause of death ...

Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

Despite Pfizer 's ( PFE 1.47%) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

Now, dozens of similar drugs are in development, as companies try to improve on the current ones. Amgen’s is among the first to show what might be possible. The data came from a Phase 2 trial ...

Clinical trials for drug development are becoming increasingly ... from diverse backgrounds can quickly evaluate and validate new algorithms. Additionally, by democratising access to advanced ...

FarmGenScience (CEO Park Hee-deok, Kim Hye-yeon) announced on the 26th that it has signed a research and development agreement with the National New Drug Development Project Group (Director Park Young ...

The last two decades have witnessed explosive growth in nanoengineering and nanomedicine. In particular, engineered ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

Scientists are using artificial intelligence and powerful computing to sculpt new molecules in an effort to treat disease.

"We are looking forward to potentially utilising new tools to increase our effectiveness in small molecule drug discovery and development." In addition to supporting its own efforts, Pfizer plans ...